Evaluation of Efficacy and Safety of Kumkumadi Ghrit in participants suffering from Facial hyperpigmentation- An open label, non-comparative, interventional, prospective, clinical study. - NI

amaskar Ayurved Private Limited0 个研究点目标入组 36 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1.Clinically diagnosed mild to moderate facial hyperpigmentation
•2.Willing to comply with all requirements of the study including being photographed, at baseline and following post treatment care and attending all treatment and follow up visits

•1.Subjects who have received facial treatments within the past three months, including laser, RF (radio frequency), HIFU (high-intensity focus ultrasound), or dermal filler injection.
•2.Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea
•3.Subjects who have used facial blemish-lightening products (such as products claiming to have whitening or blemish-lightening effects), topical or oral whitening drugs within 21 days before entering the trial
•4.Subjects on any other investigational products within 1 month prior to randomization
•5.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure.
•6.Pregnant women
•7.Known hypersensitivity to any of the ingredients of Kumkumadi Taila
•8.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

发起方

amaskar Ayurved Private Limited